• Mashup Score: 0

    This webinar will discuss a variety of topics in the management of an advanced heart failure patient. The use of contemporary therapies such as ARNI, SGLTI, novel anticoagulants, amiodarone, ablation, and inotropes in a heart transplant or LVAD candidate, and the potential implications on transplantation and durable LVAD outcomes. Attendees will gain practical insights from expert speakers on the…

    Tweet Tweets with this article
    • The #AdvancedHF #ISHLTv webinar from the #ISHLT #AHFTX IDN is TOMORROW! 🫀 💡Practical insights 💡Expert speakers 💡Contemporary therapies such as #ARNI, #SGLTI, & more 📅9 Mar, 1 p.m. EST Support patients awaiting #HeartTx or #DurableLVAD therapy. 🔗https://t.co/atXvdCybgr https://t.co/qzYo8MBwtO

  • Mashup Score: 0

    This webinar will discuss a variety of topics in the management of an advanced heart failure patient. The use of contemporary therapies such as ARNI, SGLTI, novel anticoagulants, amiodarone, ablation, and inotropes in a heart transplant or LVAD candidate, and the potential implications on transplantation and durable LVAD outcomes. Attendees will gain practical insights from expert speakers on the…

    Tweet Tweets with this article
    • NEXT WEEK: #AdvancedHF #ISHLTv webinar from the #ISHLT #AHFTX IDN. 🫀 💡Practical insights 💡Expert speakers 💡Contemporary therapies such as #ARNI, #SGLTI, & more 📅9 March, 1 p.m. EST Support your patients awaiting #HeartTx or #DurableLVAD therapy. 🔗https://t.co/atXvdCybgr https://t.co/nQ3ceAMh6f

  • Mashup Score: 2

    Initiation and up-titration of guideline-directed medical therapies (GDMTs) for heart failure with reduced ejection fraction (HFrEF) remains suboptima…

    Tweet Tweets with this article
    • 🔥Excessive fear of #AdverseEvents prevent starting of #GDMTworks in #HFrEF 👉#AE are similar in between drugs & placebo 👉Majority of #AE in #HFrEF disease-related (not drug-related) 👉New drugs #ARNI & #SGLT2i⬇️ worsening #CKD & hyperk+ @gcfmd @BiykemB https://t.co/nsYH3A9L3A https://t.co/Ad0m4dPzl6

  • Mashup Score: 0

    Amid debate over HF drug initiation and titration: a new study supports starting with sacubitril/valsartan, not switching to it.

    Tweet Tweets with this article
    • A new study observed #Angioedema risk no higher with ARNI than with RAAI #HeartFailure pts who start taking #ARNI do not appear to have a greater risk of angioedema than do those who taking an ACEI/ARB instead https://t.co/zq0frIJaei #GDMTWorks @TCTMD @ToddNeale @ShelleyZieroth